Clarity Pharmaceuticals Ltd
Clinical trials sponsored by Clarity Pharmaceuticals Ltd, explained in plain language.
-
Promising theranostic approach targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new approach that combines imaging and treatment for men with advanced prostate cancer that no longer responds to hormone therapy. The treatment uses a radioactive substance that targets a protein (PSMA) found on cancer cells. The goal is to see if it is safe a…
Phase: PHASE1, PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Disease control
Last updated May 17, 2026 04:30 UTC
-
New PET scan could sharply improve prostate cancer staging
Diagnosis Recruiting nowThis study tests a new type of PET scan using a radioactive tracer called 64Cu-SAR-bisPSMA to see if it can better detect prostate cancer that has spread to nearby lymph nodes. About 383 men with high-risk prostate cancer who are planning to have their prostate removed will get t…
Phase: PHASE3 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis
Last updated May 17, 2026 04:29 UTC